BIOMED Joins NVIDIA Inception to Advance AI-Driven Precision Medicine
BIOMED, a healthcare technology company specializing in precision and personalized medicine, has been accepted into NVIDIA Inception. This program is designed to support startups that are advancing artificial intelligence and accelerated computing. BIOMED's participation in NVIDIA Inception is a strategic move to further its mission of transforming healthcare delivery and improving access to personalized healthcare solutions. The company is currently developing OPM-AI™, its proprietary artificial intelligence platform, which is intended to support the next generation of precision and personalized medicine. By combining AI advancements with biomedical innovation, BIOMED aims to make healthcare more intelligent, accessible, and responsive to individual patient needs. As a member of NVIDIA Inception, BIOMED will gain access to a global startup ecosystem, including technical resources, developer training, preferred partner offerings, and networking opportunities within the broader AI community.